Olinder, Jon
Börjesson, Alex
Norrman, Jakob
West, Tobias
Carlström, Joakim
Gustafsson, Alexander
Annborn, Martin
Herwald, Heiko
Rydén, Cecilia
Funding for this research was provided by:
Lund University
Article History
Received: 9 March 2022
Accepted: 19 August 2022
First Online: 1 September 2022
Competing interests
: Hansa Medical (Lund, Sweden) has filed patent applications on HBP as a diagnostic marker. Heiko Herwald is listed as inventor. All other authors have no conflicts of interest to declare.